Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Benjamin N. Voorhies

Oncology | Hematology | Hematology Oncology
Intermountain Healthcare
Ihc Health Services Inc
1380 E Medical Ctr Dr, 
St George, UT 
Accepting New Patients
Offers Telehealth

Experienced in WT1-Related Wilms Tumor Syndromes
Intermountain Healthcare
Ihc Health Services Inc
1380 E Medical Ctr Dr, 
St George, UT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Benjamin Voorhies is an Oncologist and a Hematologist in St George, Utah. Dr. Voorhies is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Familial Colorectal Cancer, Intraductal Papilloma, Breast Cancer, Bone Marrow Aspiration, and Endoscopy. Dr. Voorhies is currently accepting new patients.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hematology
Hematology Oncology
Licenses
Internal Medicine in UT
Hospital Affiliations
Cedar City Hospital
Sevier Valley Hospital
Central Valley Medical Center - Cah
St. George Regional Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Deseret Mutual Benefit Administrators
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
EMI Health
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SelectHealth
  • HMO
  • POS
Steward Health Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Utah Health
  • EPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

IHC HEALTH SERVICES INC
1380 E Medical Ctr Dr, St George, UT 84790

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

A Randomized Phase II Trial of Intermittent Versus Continuous Dosing of Dabrafenib (NSC-763760) and Trametinib (NSC-763093) in BRAF V600E/K Mutant Melanoma
A Randomized Phase II Trial of Intermittent Versus Continuous Dosing of Dabrafenib (NSC-763760) and Trametinib (NSC-763093) in BRAF V600E/K Mutant Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Procedure, Drug
Study Drugs: Dabrafenib Mesylate, Trametinib Dimethyl Sulfoxide
Study Phase: Phase 2
A Phase II and Pilot Trial of PD-1 Blockade With Pembrolizumab (MK-3475) in Patients With Resectable or Unresectable Desmoplastic Melanoma (DM)
A Phase II and Pilot Trial of PD-1 Blockade With Pembrolizumab (MK-3475) in Patients With Resectable or Unresectable Desmoplastic Melanoma (DM)
Enrollment Status: Active_not_recruiting
Publish Date: September 17, 2025
Intervention Type: Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 2
A Phase II Study of Combining Talimogene Laherparepvec (T-VEC) (NSC-785349) and MK-3475 (Pembrolizumab) (NSC-776864) in Patients With Advanced Melanoma Who Have Progressed on Anti-PD1/L1 Based Therapy
A Phase II Study of Combining Talimogene Laherparepvec (T-VEC) (NSC-785349) and MK-3475 (Pembrolizumab) (NSC-776864) in Patients With Advanced Melanoma Who Have Progressed on Anti-PD1/L1 Based Therapy
Enrollment Status: Active_not_recruiting
Publish Date: May 07, 2025
Intervention Type: Biological
Study Drugs: Pembrolizumab, Talimogene Laherparepvec
Study Phase: Phase 2
A Phase II Randomized Study of Nivolumab (NSC-748726) With Ipilimumab (NSC-732442) or Ipilimumab Alone in Advanced Melanoma Patients Refractory to an Anti-PD1 or Anti-PD-L1 Agent
A Phase II Randomized Study of Nivolumab (NSC-748726) With Ipilimumab (NSC-732442) or Ipilimumab Alone in Advanced Melanoma Patients Refractory to an Anti-PD1 or Anti-PD-L1 Agent
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Biological
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
A Phase I, Open-label, Multicenter Study Investigating the Tolerability and Efficacy of UV1 Vaccine in First-line Malignant Melanoma Patients Planned for Treatment With Pembrolizumab
A Phase I, Open-label, Multicenter Study Investigating the Tolerability and Efficacy of UV1 Vaccine in First-line Malignant Melanoma Patients Planned for Treatment With Pembrolizumab
Enrollment Status: Completed
Publish Date: August 22, 2024
Intervention Type: Drug
Study Drugs: UV1, GM-CSF
Study Phase: Phase 1
Phase II Neoadjuvant Trial of Nivolumab in Combination With HF10 Oncolytic Viral Therapy in Resectable Stage IIIB, IIIC, IVM1a Melanoma (Neo-NivoHF10)
Phase II Neoadjuvant Trial of Nivolumab in Combination With HF10 Oncolytic Viral Therapy in Resectable Stage IIIB, IIIC, IVM1a Melanoma (Neo-NivoHF10)
Enrollment Status: Terminated
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

3 Total Publications

Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanoma.
Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanoma.
Journal: Journal for immunotherapy of cancer
Published: December 29, 2020
View All 3 Publications
Similar Doctors
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Ryan E. Wilcox
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Ryan E. Wilcox
Hematology Oncology | Hematology | Oncology

Ihc Health Services Inc

St George, UT 
 (6.9 miles away)
435-688-4700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ryan Wilcox is a Hematologist Oncology specialist and a Hematologist in St George, Utah. Dr. Wilcox is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Oral Squamous Cell Carcinoma, Colorectal Cancer, Multiple Myeloma, Sertoli-Leydig Cell Tumor, and Bone Marrow Aspiration. Dr. Wilcox is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Joseph D. Te
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Joseph D. Te
Hematology Oncology | Hematology | Oncology

Central Utah Clinic PC

2019 E Riverside Dr, Suite A200, 
St George, UT 
 (0.8 miles away)
435-628-9298
Languages Spoken:
English, Filipino
See accepted insurances
Accepting New Patients
Offers Telehealth

Joseph Te is a Hematologist Oncology specialist and a Hematologist in St George, Utah. Dr. Te is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Non-Hodgkin Lymphoma, and Angiosarcoma. Dr. Te is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Terence D. Rhodes
Hematology Oncology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Terence D. Rhodes
Hematology Oncology | Oncology

Ihc Health Services Inc

St George, UT 
 (6.9 miles away)
435-634-9850
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Terence Rhodes is a Hematologist Oncology specialist and an Oncologist in St George, Utah. Dr. Rhodes is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Colorectal Cancer, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), Bone Marrow Aspiration, and Endoscopy. Dr. Rhodes is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Voorhies's expertise for a condition
ConditionClose
      • Advanced
      • ALK-Positive Non-Small Cell Lung Cancer
        Dr. Voorhies is
        Advanced
        . Learn about ALK-Positive Non-Small Cell Lung Cancer.
        See more ALK-Positive Non-Small Cell Lung Cancer experts
      • Angiosarcoma
        Dr. Voorhies is
        Advanced
        . Learn about Angiosarcoma.
        See more Angiosarcoma experts
      • Breast Cancer
        Dr. Voorhies is
        Advanced
        . Learn about Breast Cancer.
        See more Breast Cancer experts
      • Cholangiocarcinoma (Bile Duct Cancer)
        Dr. Voorhies is
        Advanced
        . Learn about Cholangiocarcinoma (Bile Duct Cancer).
        See more Cholangiocarcinoma (Bile Duct Cancer) experts
      • Familial Colorectal Cancer
        Dr. Voorhies is
        Advanced
        . Learn about Familial Colorectal Cancer.
        See more Familial Colorectal Cancer experts
      • Inflammatory Breast Cancer
        Dr. Voorhies is
        Advanced
        . Learn about Inflammatory Breast Cancer.
        See more Inflammatory Breast Cancer experts
      View All 13 Advanced Conditions
      • Experienced
      • Acinic Cell Carcinoma of Salivary Glands
        Dr. Voorhies is
        Experienced
        . Learn about Acinic Cell Carcinoma of Salivary Glands.
        See more Acinic Cell Carcinoma of Salivary Glands experts
      • Acute Mountain Sickness
        Dr. Voorhies is
        Experienced
        . Learn about Acute Mountain Sickness.
        See more Acute Mountain Sickness experts
      • Adenoid Cystic Carcinoma
        Dr. Voorhies is
        Experienced
        . Learn about Adenoid Cystic Carcinoma.
        See more Adenoid Cystic Carcinoma experts
      • Adult Immune Thrombocytopenia
        Dr. Voorhies is
        Experienced
        . Learn about Adult Immune Thrombocytopenia.
        See more Adult Immune Thrombocytopenia experts
      • Adult Soft Tissue Sarcoma
        Dr. Voorhies is
        Experienced
        . Learn about Adult Soft Tissue Sarcoma.
        See more Adult Soft Tissue Sarcoma experts
      • Adult T-Cell Leukemia
        Dr. Voorhies is
        Experienced
        . Learn about Adult T-Cell Leukemia.
        See more Adult T-Cell Leukemia experts
      View All 102 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2025 All Rights Reserved